Supranuclear Palsy, Progressive: all 171 studies
Page 2 of 2. Open to participants first (51), then studies with results posted, then the rest; newest registration first within each.
- tDCS Plus Physical Therapy for Progressive Supranuclear PalsyCompletedNCT04237948Not applicable
- Cerebellar rTMS Theta Burst for Postural Instability in Progressive Supranuclear PalsyCompletedNCT04222218Not applicable
- A Study to Test the Safety and Tolerability of UCB0107 in Study Participants With Progressive Supranuclear Palsy (PSP)CompletedNCT04185415Phase 1
- Study of NBMI Treatment in Patients With Atypical Parkinsons (PSP or MSA)CompletedNCT04184063Phase 2
- Oxford Study of Quantification in ParkinsonismStatus unknownNCT04139551
- Pathophysiology of Gait and Posture in Progressive Supranuclear PalsyCompletedNCT04096651Not applicable
- Treatment of Disturbed Sleep in Progressive Supranuclear Palsy (PSP)CompletedNCT04014387Phase 4
- A Study to Assess Tolerability, Safety, Pharmacokinetics and Effect of AZP2006 in Patients With PSPCompletedNCT04008355Phase 2
- Tau Imaging With JNJ067CompletedNCT03926702Early Phase 1
- Trial of Parkinson's And Zoledronic AcidCompletedNCT03924414Phase 4
- 18F-PM-PBB3 PET Study in Tauopathy Including Alzheimer's Disease, Other Dementias and Normal ControlsCompletedNCT03625128Early Phase 1
- Phase 1 Test-retest Evaluation of [18F]MNI-958 PETCompletedNCT03545789Phase 1
- Human CNS Tau Kinetics in TauopathiesCompletedNCT03545126
- Neuropsychological Evaluation for Early Diagnosis of PSPCompletedNCT03478124
- Cognitive Impairement In Frontotemporal DementiaCompletedNCT03452956
- Safety and Efficacy of Droxidopa for Fatigue in Patients With ParkinsonismWithdrawnNCT03446807Phase 2
- Extension Study of ABBV-8E12 in Patients With Progressive Supranuclear Palsy (PSP) Who Completed Study C2N-8E12-WW-104CompletedNCT03413319Phase 1
- Epidemiology and Pathophysiology of Parkinsonism in the CaribbeansStatus unknownNCT03368300Not applicable
- Chromatic Pupillometry to Assess the Melanopsin-Light Pathway in Progressive Supranuclear PalsyStatus unknownNCT03330353
- Brain Network Activation in Patients With Movement DisordersStatus unknownNCT03269201
- Evaluation of [18F]MNI-952 as a Potential PET Radioligand for Imaging Tau Protein in the BrainCompletedNCT03080051Early Phase 1
- More Than a Movement Disorder: Applying Palliative Care to Parkinson's DiseaseCompletedNCT03076671Not applicable
- Phase 0 Evaluation of [18F]MNI-958 as a Potential PET Radioligand for Imaging Tau Protein in the BrainCompletedNCT03058965Early Phase 1
- ADDIA Proof-of-Performance Clinical StudyCompletedNCT03030586
- Gait Analysis in Neurological DiseaseActive, not recruitingNCT02994719
- 4-Repeat Tauopathy Neuroimaging Initiative - Cycle 2CompletedNCT02966145
- Vaccination Uptake (VAX) in PDCompletedNCT02874274Not applicable
- Efficacy of RIVAstigmine on Motor, Cognitive and Behavioural Impairment in Progressive Supranuclear PalsyCompletedNCT02839642Phase 3
- PROgressive Supranuclear Palsy CorTico-Basal Syndrome Multiple System Atrophy Longitudinal Study UKStatus unknownNCT02778607
- Biomarkers in Neural DisordersCompletedNCT02761707
- Deep TMS for the Treatment of Patients With Parkinson's Disease and Progressive Supranuclear PalsyCompletedNCT02734485Not applicable
- Extension Study of BIIB092 in Participants With Progressive Supranuclear Palsy (PSP) Who Participated in CN002003TerminatedNCT02658916Phase 1
- Evaluation of [18F]MNI-815 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With TauopathiesCompletedNCT02531360Early Phase 1
- Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear PalsyCompletedNCT02494024Phase 1
- Young Plasma Transfusions for Progressive Supranuclear PalsyCompletedNCT02460731Phase 1
- Multiple Ascending Dose Study of Intravenously Administered BMS-986168 (BIIB092) in Patients With Progressive Supranuclear PalsyCompletedNCT02460094Phase 1
- Magnetic Resonance Imaging in the Diagnosis of Parkinsonian SyndromesTerminatedNCT02445469Not applicable
- A 6 Month, Open-Label, Pilot Futility Clinical Trial of Oral Salsalate for Progressive Supranuclear PalsyCompletedNCT02422485Phase 1
- Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)CompletedNCT02365922
- Study of the Neural Basis of Analogical ReasoningCompletedNCT02236832Not applicable
- 2-(1-{6-[(2-[F-18]Fluoroethyl) (Methyl)Amino]-2-naphthyl} Ethylidene) Malononitrile-PET for in Vivo Diagnose of Tauopathy in Unclassified ParkinsonismCompletedNCT02214862Early Phase 1
- Safety Study of TPI-287 to Treat CBS and PSPCompletedNCT02133846Phase 1
- Defining Phenotypes of Movement Disorders :Parkinson's Plus Disorders (PD), Essential Tremor (ET), Cortical Basal Degeneration (CBD), Multiple Systems Atrophy (MSA), Magnetoencephalography.CompletedNCT02132052
- Rehabilitation in Patients With Progressive Supranuclear PalsyCompletedNCT02109393Not applicable
- Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy SubjectsCompletedNCT02103894Phase 1
- Identifying Biomarkers of Parkinson's Disease Using Magnetic Resonance Imaging (MRI)CompletedNCT01888185
- Clinical Trial to Evaluate Bone Marrow Stem Cell Therapy for PSP, a Rare Form of ParkinsonismStatus unknownNCT01824121Phase 1/2
- Foot Mechanical Stimulation for Treatment of Gait and Gait Related Disorders in Parkinson's Disease and Progressive Supranuclear Palsy.TerminatedNCT01815281Not applicable
- 4 Repeat Tauopathy Neuroimaging InitiativeCompletedNCT01804452
- Robot Walking Rehabilitation in Parkinson's DiseaseCompletedNCT01668407Not applicable
- Postural Instability in Progressive Supranuclear PalsyCompletedNCT01563276
- Analysis of the Enteric Nervous System Using Colonic BiopsiesCompletedNCT01353183Not applicable
- Evaluating Cerebrospinal Fluid Biomarkers in Alzheimer's, Progressive Supranuclear Palsy Subjects, and ControlsCompletedNCT01348061
- Efficacy, Tolerability and Safety of Azilect in Subjects With Progressive Supranuclear PalsyTerminatedNCT01187888Phase 3
- Repetitive Transcranial Magnetic Stimulation (TMS) for Progressive Supranuclear Palsy and Corticobasal DegenerationCompletedNCT01174771
- Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear PalsyCompletedNCT01110720Phase 2/3
- Davunetide (AL-108) in Predicted Tauopathies - Pilot StudyCompletedNCT01056965Phase 1
- Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112 Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear PalsyCompletedNCT01049399Not applicable
- Diagnostic and Prognostic Biomarkers in Parkinson DiseaseStatus unknownNCT00653783
- A Pilot Clinical Trial of Pyruvate, Creatine, and Niacinamide in Progressive Supranuclear Palsy.CompletedNCT00605930Not applicable
- Effects of Coenzyme Q10 in PSP and CBDCompletedNCT00532571Phase 2/3
- Efficacy Study for Treatment of Dementia in Progressive Supranuclear PalsyStatus unknownNCT00522015Phase 2
- Research of Biomarkers in Parkinson DiseaseCompletedNCT00465790
- Risk Factors for Progressive Supranuclear Palsy (PSP)CompletedNCT00431301
- Trial of Valproic Acid in Patients With Progressive Supranuclear Palsy (Depakine)CompletedNCT00385710Phase 2
- Transcranial Duplex Scanning and Single Photon Emission Computer Tomography (SPECT) in Parkinsonian SyndromesCompletedNCT00368199
- Study About Safety and Efficacy of Coenzyme Q10 in Progressive Supranuclear PalsyCompletedNCT00328874Phase 2
- Neuroprotection and Natural History in Parkinson's Plus Syndromes (NNIPPS)TerminatedNCT00211224Phase 3
- Study of the Distractibility Syndrome in Patients With Progressive Supranuclear PalsyStatus unknownNCT00139373Phase 2
- Continuously Infused Recombinant-Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (GDNF) to Treat Progressive Supranuclear PalsyCompletedNCT00005903Phase 2
- Diagnosis and Natural History Study of Patients With Neurological ConditionsCompletedNCT00001549